Expectant Management in Pregnancies with Severe Pre-eclampsia

Seminars in Perinatology

Volumn 33, Issue 3, 2009, Pages 143-151

  Haddad, Bassam ^a   Sibai, Baha M ^b  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

expectant management; management; preeclampsia; severe preeclampsia

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETAMETHASONE; CORTICOSTEROID; DIAZEPAM; DIHYDRALAZINE; MAGNESIUM SULFATE; METHYLDOPA; NIFEDIPINE; PLACEBO; PLASMA SUBSTITUTE; PRAZOSIN;

ALGORITHM; ANTIHYPERTENSIVE THERAPY; BED REST; CARDIOTOCOGRAPHY; CELL DAMAGE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; DELIVERY; DISEASE SEVERITY; DOPPLER FLOWMETRY; ECLAMPSIA; ENDOTHELIUM CELL; FETUS DEATH; FETUS LUNG MATURATION; GESTATIONAL AGE; HELLP SYNDROME; HIGH RISK PREGNANCY; HUMAN; HYPERTENSION; INTRAUTERINE GROWTH RETARDATION; KIDNEY DISEASE; MATERNAL HYPERTENSION; MATERNAL WELFARE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN MORBIDITY; NEWBORN MORTALITY; PATIENT SELECTION; PRACTICE GUIDELINE; PREECLAMPSIA; PRIORITY JOURNAL; PROTEINURIA; RECURRENT DISEASE; REVIEW; RISK BENEFIT ANALYSIS; SOLUTIO PLACENTAE; TREATMENT INDICATION; UMBILICAL ARTERY;

FEMALE; HUMANS; INFANT, NEWBORN; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 65649139167     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semperi.2009.02.002     Document Type: Review

References (39)

1. American College of Obstetricians and Gynecologists. Hypertension in Pregnancy (1996), The College, Washington Technical Bulletin No. 219
2. Sibai B.M., and Barton J.R. Expectant management of severe preeclampsia remote from term: Patient selection, treatment, and delivery indications. Am J Obstet Gynecol 196 (2007) 514.e1-514.e9
3. Schiff E., Friedman S.A., Mercer B.M., et al. Fetal lung maturity is not accelerated in preeclamptic pregnancies. Am J Obstet Gynecol 169 (1993) 1096-1101
4. Crowley P. Antenatal corticosteroid therapy: A metal-analysis of the randomized trials, 1972-1994. Am J Obstet Gynecol 173 (1995) 322-335
5. Sibai B.M., Akl S., Fairlie F., et al. A protocol for managing severe preeclampsia in the second trimester. Am J Obstet Gynecol 163 (1990) 733-738
6. Odendaal H.J., Pattinson R.C., Bam R., et al. Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks' gestation: A randomized controlled trial. Obstet Gynecol 76 (1990) 1070-1075
7. Sibai B.M., Mercer B.M., Schiff E., et al. Aggressive versus expectant management of severe preeclampsia at 28-32 weeks' gestation: A randomized controlled trial. Am J Obstet Gynecol 171 (1994) 818-822
8. Pattinson R.C., Odendaal H.J., and du Toit R. Conservative management of severe proteinuric hypertension before 28 weeks' gestation. S Afr Med J 73 (1988) 516-518
9. Gaugler-Senden I.P., Huijssoon A.G., Visser W., et al. Maternal and perinatal outcome of preeclampsia with an onset before 24 weeks' gestation. Audit in a tertiary referral center. Eur J Obstet Gynecol Reprod Biol 128 (2006) 216-221
10. Budden A., Wilkinson L., Buksh M.J., et al. Pregnancy outcome in women presenting with pre-eclampsia at less than 25 weeks gestation. Aust N Z J Obstet Gynaecol 46 (2006) 407-412
11. Sezik M., Tuncay G., and Yapar E.G. Prediction of adverse neonatal outcomes in preeclampsia by absent or reversed end-diastolic flow velocity in the umbilical artery. Gynecol Obstet Invest 57 (2004) 109-113
12. Bombrys A.E., Barton J.R., Nowacki E.A., et al. Expectant management of severe preeclampsia at less than 27 weeks' gestation: Maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management. Am J Obstet Gynecol 199 (2008) e1-e6
13. Odendaal H.J., Pattinson R.C., and du Toit R. Fetal and neonatal outcome in patients with severe pre-eclampsia before 34 weeks. S Afr Med J 71 (1987) 555-558
14. Olah K.S., Redman C.W., and Gee H. Management of severe, early pre-eclampsia: Is conservative management justified?. Eur J Obstet Gynecol Reprod Biol 51 (1993) 175-180
15. Visser W., and Wallenburg H.C. Maternal and perinatal outcome of temporizing management in 254 consecutive patients with severe pre-eclampsia remote from term. Eur J Obstet Gynecol Reprod Biol 63 (1995) 147-154
16. Visser W., and Wallenburg H.C. Temporising management of severe pre-eclampsia with and without the HELLP syndrome. Br J Obstet Gynaecol 102 (1995) 111-117
17. Hall D.R., Odendaal H.J., Steyn D.W., et al. Expectant management of early onset, severe pre-eclampsia: Maternal outcome. Br J Obstet Gynaecol 107 (2000) 1252-1257
18. Hall D.R., Odendaal H.J., Kirsten G.F., et al. Expectant management of early onset, severe pre-eclampsia: Perinatal outcome. Br J Obstet Gynaecol 107 (2000) 1258-1264
19. Vigil-De Gracia P., Montufar-Rueda C., and Ruiz J. Expectant management of severe preeclampsia and preeclampsia superimposed on chronic hypertension between 24 and 34 weeks' gestation. Eur J Obstet Gynecol Reprod Biol 107 (2003) 24-27
20. Haddad B., Deis S., Goffinet F., et al. Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks' gestation. Am J Obstet Gynecol 190 (2004) 1590-1597
21. Oettle C., Hall D., Roux A., et al. Early onset severe pre-eclampsia: Expectant management at a secondary hospital in close association with a tertiary institution. Br J Obstet Gynaecol 112 (2005) 84-88
22. 6/7 weeks' gestation: Maternal and perinatal outcomes according to gestational age by X weeks at onset of expectant management. Am J Perinatol (2009) (in press)
23. Chammas M.F., Nguyen T.M., Li M.A., et al. Expectant management of severe preterm preeclampsia: Is intrauterine growth restriction an indication for immediate delivery?. Am J Obstet Gynecol 183 (2000) 853-858
24. Shear R.M., Rinfret D., and Leduc L. Should we offer expectant management in cases of severe preterm preeclampsia with fetal growth restriction?. Am J Obstet Gynecol 192 (2005) 1119-1125
25. Haddad B., Kayem G., Sies S., et al. Are perinatal and maternal outcomes different during expectant management of severe preeclampsia in the presence of intrauterine growth restriction?. Am J Obstet Gynecol 196 (2007) 237.e1-237.e5
26. Karsdorp V.H.M., van Vugt J.M.G., van Geijn H.P., et al. Clinical significance of absent or reversed end diastolic velocity waveforms in umbilical artery. Lancet 344 (1994) 1664-1668
27. Yoon B.H., Lee C.M., and Kim S.W. An abnormal umbilical artery waveform: A strong and independent predictor of adverse perinatal outcome in patients with preeclampsia. Am J Obstet Gynecol 171 (1994) 713-721
28. Pattinson R.C., Norman K., and Odendaal H.J. The role of Doppler velocimetry in the management of high risk pregnancies. Br J Obstet Gynaecol 101 (1994) 114-120
29. Guzman E.R., Vintzileos A.M., Martins M., et al. The efficacy of individual computer heart rate indices in detecting acidemia at birth in growth-restricted fetuses. Obstet Gynecol 87 (1996) 969-974
30. Serra V., Moulden M., Bellver J., et al. The value of the short-term fetal heart rate variation for timing the delivery of growth-retarded fetuses. Br J Obstet Gynaecol 115 (2008) 1101-1107
31. Amorim M.M., Santos L.C., and Faundes A. Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia. Am J Obstet Gynecol 180 (1999) 1283-1288
32. Schiff E., Friedman S.A., Kao L., et al. The importance of urinary excretion during conservative management of severe preeclampsia. Am J Obstet Gynecol 175 (1996) 1313-1316
33. Hall D.R., Odendaal H.J., Stein D.W., et al. Urinary protein excretion and expectant management of early onset, severe preeclampsia. Int J Gynecol Obstet 77 (2002) 1-6
34. Chua S., and Redman C.W.G. Prognosis for preeclampsia complicated by 5g or more of proteinuria in 24 hours. Eur J Obstet Gynecol Reprod Biol 43 (1992) 9-12
35. Newman M.G., Robichaux A.G., Stedman C.M., et al. Perinatal outcomes in preeclampsia that is complicated by massive proteinuria. Am J Obstet Gynecol 188 (2003) 264-268
36. Ganzevoort W., Rep A., Bonsel G.J., et al. A randomised controlled trial comparing two temporising management strategies, one with and one without plasma volume expansion, for severe and early onset pre-eclampsia. Br J Obstet Gynaecol 112 (2005) 1358-1368
37. Chari R.S., Friedman S.A., O'Brien J.M., et al. Daily antenatal testing in women with severe preeclampsia. Am J Obstet Gynecol 17 (1995) 1207-1210
38. Hall D.R., Odendaal J.H., and Steyn D.W. Delivery of patients with early onset, severe preeclampsia. Int J Gynecol Obstet 74 (2001) 143-150
39. Alanis M.C., Robinson C.J., Hulsey T.C., et al. Early onset severe preeclampsia: Induction of labor vs. elective Cesarean delivery and neonatal outcomes. Am J Obstet Gynecol 199 (2008) 262.e1-262.e6